RL-603

• Description:

  RL-603 is the metabolite of Anagrelide (HY-B0523) . RL-603 exhibits platelet-lowering activity in mouse model[1].

• UNSPSC:

  12352005

• Hazard Statement:

  H302-H315-H319-H335

• Target:

  Drug Metabolite

• Type:

  Natural Products

• Related Pathways:

  Metabolic Enzyme/Protease

• Field of Research:

  Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/rl-603.html

• Smiles:

  ClC1=CC=C2NC(N)=NCC2=C1Cl

• Molecular Formula:

  C8H7Cl2N3

• Molecular Weight:

  216.07

• Precautions:

  P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

• References & Citations:

  [1]Erusalimsky JD, et al., Is the platelet lowering activity of anagrelide mediated by its major metabolite 2-amino-5,6-dichloro-3,4-dihydroquinazoline (RL603) ? Exp Hematol. 2002 Jul;30 (7) :625-6; author reply 626-7.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Natural Products

• Clinical Information:

  No Development Reported

• CAS Number:

  444904-63-6